In the BioHarmony Drug Report Database

"Preview" Icon

Aldesleukin

Proleukin (aldesleukin) is a protein pharmaceutical. Aldesleukin was first approved as Proleukin on 1992-05-05. It is used to treat colorectal neoplasms, HIV infections, melanoma, multiple myeloma, and non-hodgkin lymphoma amongst others in the USA.

 

Trade Name

 

Proleukin
 

Common Name

 

aldesleukin
 

ChEMBL ID

 

CHEMBL1201438
 

Indication

 

colorectal neoplasms, hiv infections, melanoma, multiple myeloma, non-hodgkin lymphoma, renal cell carcinoma
 

Drug Class

 

Interleukins: interleukin-2 analogues and derivatives

Image (chem structure or protein)

Aldesleukin structure rendering